Park Dental Partners, Inc. (PARK) company profile
Close on Nov 17, 2026Market cap $92.06MP/E –Yield –
About Park Dental Partners
Services-Misc Health & Allied Services, NEC, SIC 8090
Park Dental Partners, Inc. operates as a dental resource organization that delivers business support services to affiliated dental practices. The company supplies clinical support staff, administrative personnel, facilities, equipment, and centralized administrative functions such as billing, collections, scheduling, and information technology. Through long-term agreements, its affiliated network provides general and specialty dental care, including oral surgery, periodontics, pediatric dentistry, prosthodontics, endodontics, and orthodontics. Its direct clients are affiliated dental practices, while the network serves individual patients seeking preventative, routine, and specialized oral care.
The organization supports 86 practice locations across Minnesota, Wisconsin, and Arizona, with its largest concentration of operations located in the Minneapolis and St. Paul metropolitan area. Its supported network includes 214 dentists along with 990 hygienists, dental assistants, and patient care coordinators. The enterprise is incorporated in Minnesota.
Summary of the business section of Park Dental Partners's latest annual report, written by StockData.
Company profile
Company
- Legal name
- Park Dental Partners, Inc.
- Founded
- 1972
- Headquarters
- Roseville, MN
- Address
- 2200 County Road C West, Suite 2210 55113
- Phone
- (651) 633-0500
- Website
- parkdentalpartners.com
- Employees
- 1,212, Dec 31, 2025
- Industry
- Services-Misc Health & Allied Services, NEC
- Incorporated in
- Minnesota
- Fiscal year ends
- December 31
Stock & identifiers
- Ticker
- PARK
- Exchange
- Nasdaq
- IPO date
- Dec 3, 2025
- Shares outstanding
- 5M, Aug 13, 2026
- Filer category
- Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
- SEC CIK
- 2069604
- CUSIP
- 700402100
- ISIN
- US7004021009
- FIGI
- BBG01X1GFQB3
- Share class FIGI
- BBG01X1GFRT2
- LEI
- 529900JGYNTREBZJHT94
- EIN
- 93-2020683
Executives and directors
Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years
| Name | Position | Shares owned |
|---|---|---|
| Alan Siems Law | See Remarks, Director | 181,001 |
| Peter G. Swenson | CEO and Chairman, Director | 238,381 |
| Christopher James Bernander | Chief Financial Officer, Director | 55,756 |
| Christopher Eugene Steele | See Remarks, Director | 137,172 |
| Philip Irving Smith | Director | 3,569 |
| Anna Marie Schaefer | Director | 2,800 |
| Christopher Charles Smith | Director | 10,492 |
| Todd Christopher Gerlach | Director | 68,847 |
Executive compensation, fiscal 2025
Summary compensation table from the latest proxy statement
| Executive | Salary | Bonus | Other | Total | vs. prior year |
|---|---|---|---|---|---|
| Christopher J. Bernander Chief Financial Officer, Treasurer | $425.00K | $274.71K | $16.14K | $715.85K | -27% |
| Dr. Alan Law Chief Clinical Officer, Specialty Practices | $675.28K | $96.96K | $106.29K | $878.53K | -12% |
| Dr. Christopher Steele Chief Clinical Officer, General Practices | $529.34K | $193.91K | $18.63K | $741.87K | -5% |
| Peter G. Swenson Chairman of the Board, President and Chief Executive Officer | $602.55K | $584.21K | $19.40K | $1.21M | -54% |
Stock and option awards are grant-date fair values, not realized pay. “Other” includes pension value changes and all other compensation. Source proxy statement.
IPO
From the final prospectus (Form 424B4) and the first day of trading
Offering
- Type
- Initial public offering
- Final prospectus filed
- Dec 3, 2025
- Offer price
- $13.00
- Securities offered
- 1,535,000
- Gross proceeds
- $19.96M
- Exchange
- Nasdaq
- First trading day
- Dec 3, 2025
- First-day close
- $10.25-21.2%
- Lock-up ends (est.)
- Jun 1, 2026
“The initial public offering price of our Common Stock is $13.00 per share.”
Lock-up end is estimated as 180 days after the first trading day; the prospectus sets the actual terms.
Corporate history
Events identified from SEC filings
| Date | Event | Details |
|---|---|---|
| Nov 9, 2026 | Acquisition / sale | Completion of acquisition or disposition of assets (8-K Item 2.01) |
| Dec 3, 2025 | IPO | Initial public offering priced (424B4 prospectus) |
| Nov 20, 2025 | Listing | Registration of securities on an exchange (Form 8-A) |
See a number that looks wrong?